Foresight Global Investors, Inc. Astrazeneca PLC Transaction History

Foresight Global Investors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $600,456 - $672,154	-9,702 Reduced 3.62%	258,028 $17.4 Billion
Q3 2023 Oct 23, 2023	BUY	$64.85 - $71.7 $906,927 - $1 Million	13,985 Added 5.51%	267,730 $18.1 Billion
Q2 2023 Jul 24, 2023	SELL	$69.91 - $75.81 $2.32 Million - $2.51 Million	-33,120 Reduced 11.55%	253,745 $18.2 Billion
Q1 2023 Apr 13, 2023	BUY	$63.15 - $71.6 $18.1 Million - $20.5 Million	286,865 New	286,865 $19.9 Billion

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Foresight Global Investors, Inc., based on Form 13F filings with the SEC.

Stay updated on Foresight Global Investors, Inc. with notifications on news.